The ethics of community-based research with people who use drugs: results of a scoping review. Issue 1 (December 2016)

• Record Type: Journal Article
• Authors: Souleymanov, Rusty; Kuzmanović, Dario; Marshall, Zack; Scheim, Ayden; Mikiki, Mikiki; Worthington, Catherine; Millson, Margaret
• Is Part Of: BMC medical ethics. Volume 17:Issue 1(2016)
• Page Start: 1
• Page End: 13
• Publication Date: 2016-12
• Subjects: Scoping review -- Community-based participatory research -- Ethics -- People who use drugs -- Challenges -- Incentives -- Exclusion -- Diversity; Medical ethics -- Periodicals; 172.205
• DOI: 10.1186/s12910-016-0108-2
• Languages: English
• ISSNs: 1472-6939

Abstract

Abstract Background Drug user networks and community-based organizations advocate for greater, meaningful involvement of people with lived experience of drug use in research, programs and services, and policy initiatives. Community-based approaches to research provide an opportunity to engage people who use drugs in all stages of the research process. Conducting community-based participatory research (CBPR) with people who use drugs has its own ethical challenges that are not necessarily acknowledged or supported by institutional ethics review boards. We conducted a scoping review to identify ethical issues in CBPR with people who use drugs that were documented in peer-reviewed and grey literature. Methods The search strategy focused on three areas; community-based research, ethical issues, and drug use. Searches of five academic databases were conducted in addition to a grey literature search, hand-searching, and consultation with organizational partners and key stakeholders. Peer reviewed literature and community reports published in English between 1985 and 2013 were included, with initial screening conducted by two reviewers. Results The search strategy produced a total of 874 references. Twenty-five references met the inclusion criteria and were included in our thematic analysis. Five areas were identified as important to the ethics of CBPR with people who use drugs: 1) participant compensation, 2) drug user perspectives on CBPR, 3) peer recruitment and representation in CBPR, 4) capacity building, and 5) participation and inclusion in CBPR. Conclusions We critically discuss implications of the emerging research in this field and provide suggestions for future research and practice.